Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome

Clinical trial NCT06437210 · COMPLETED

Trial details

NCT number: NCT06437210
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Post-COVID-19 Syndrome COVID-19 Dyspnea Fatigue Cough Inflammation

Start date: 2022-02-15
Primary completion: 2023-12-15
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.